日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects.

老年急性髓系白血病患者的微移植:安全性、有效性和免疫学效应的初步研究

Sung Anthony D, Jauhari Shekeab, Siamakpour-Reihani Sharareh, Rao Arati V, Staats Janet, Chan Cliburn, Meyer Everett, Gadi Vijayakrishna K, Nixon Andrew B, Lyu Jing, Xie Jichun, Bohannon Lauren, Li Zhiguo, Hourigan Christopher S, Dillon Laura W, Wong Hong Yuen, Shelby Rebecca, Diehl Louis, de Castro Carlos, LeBlanc Thomas, Brander Danielle, Erba Harry, Galal Ahmed, Stefanovic Alexandra, Chao Nelson, Rizzieri David A

Phase 2 Study of Dose-Reduced Consolidation Radiation Therapy in Diffuse Large B-Cell Lymphoma

弥漫性大B细胞淋巴瘤剂量降低巩固放射治疗的II期研究

Kelsey, Chris R; Broadwater, Gloria; James, Olga; Chino, Junzo; Diehl, Louis; Beaven, Anne W; Chang, Catherine; Koontz, Bridget F; Prosnitz, Leonard R

Dose-intense chemoimmunotherapy plus radioimmunotherapy in high-risk diffuse large B-cell lymphoma and mantle cell lymphoma: a phase II study

高危弥漫性大B细胞淋巴瘤和套细胞淋巴瘤的剂量强化化疗免疫疗法联合放射免疫疗法:一项II期研究

Hudson, Kathryn E; Rizzieri, David; Thomas, Samantha M; LeBlanc, Thomas W; Powell, Zachary; Diehl, Louis; Moore, Joseph O; DeCastro, Carlos; Beaven, Anne W

Phase II open label study of the oral vascular endothelial growth factor-receptor inhibitor PTK787/ZK222584 (vatalanib) in adult patients with refractory or relapsed diffuse large B-cell lymphoma

一项针对难治性或复发性弥漫性大B细胞淋巴瘤成年患者的II期开放标签研究,评估口服血管内皮生长因子受体抑制剂PTK787/ZK222584(vatalanib)的疗效。

Brander, Danielle; Rizzieri, David; Gockerman, Jon; Diehl, Louis; Shea, Thomas Charles; Decastro, Carlos; Moore, Joseph O; Beaven, Anne

Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia

急性髓系白血病患者根据第14天骨髓活检结果决定再诱导治疗方案

Morris, Tod A; DeCastro, Carlos M; Diehl, Louis F; Gockerman, Jon P; Lagoo, Anand S; Li, Zhiguo; Moore, Joseph O; Rizzieri, David A; Rao, Arati V